A Form 4 filed on November 5, 2026 reports that Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc., sold 306 shares of common stock on November 3, 2026 under a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc. (NYSE:LH)
  • Transaction: Disposition (code S) of 306 shares of common stock on November 3, 2026
  • Sale price: $353.70 per share
  • Remaining holdings: 6,844.9105 shares of common stock directly owned following the transaction
  • 10b5-1 plan: The sale was made pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended
  • Filing signed: By Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn, dated November 5, 2026

Vaughn's November 2026 Rule 10b5-1 Share Sale at Labcorp

According to the filing, Bryan T. Vaughn, identified as EVP and President, Diagnostics of Labcorp Holdings Inc. (NYSE:LH), disposed of 306 shares of the company's common stock on November 3, 2026, at a price of $353.70 per share. The transaction is recorded in Table I of the Form 4 as a sale (transaction code S) of directly owned securities.

The filing discloses that the sale was executed "pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended," as indicated by the checked box on the form and the accompanying footnote. Following the reported transaction, Vaughn is disclosed as directly beneficially owning 6,844.9105 shares of Labcorp common stock. No derivative securities transactions were reported in Table II of this filing.

The Form 4 was signed by Kathryn W. Kyle as Attorney-in-Fact for Bryan T. Vaughn and filed with the SEC on November 5, 2026, with the date of the earliest transaction listed as November 3, 2026. The filing indicates it was made by one reporting person. No amendment date is provided, indicating this is an original filing.

What Was Disclosed

The filing reports a single open-market sale of 306 Labcorp Holdings Inc. common shares by EVP Bryan T. Vaughn on November 3, 2026, at $353.70 per share, conducted under a pre-established Rule 10b5-1 trading plan, leaving him with 6,844.9105 directly held shares.